In this episode of The Pharma Podcast  we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19. My guest is Tiana DiMichele, Director, Business Development, Impres Inc. Contact Information: Tiana DiMichele, Director, Business Development Phone: <a href='tel:%28416%29%20%20885-0023'>(416) 885-0023</a> | E-mail: <a href='mailto:tianadimichele@imprespharma.ca'>tianadimichele@imprespharma.ca</a>

In this episode of The Pharma Podcast we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19. My guest is Tiana DiMichele, Director, Business Development, Impres Inc. Contact Information: Tiana DiMichele, Director, Business Development Phone: (416) 885-0023 | E-mail: tianadimichele@imprespharma.ca

In this episode of The Pharma Podcast &nbsp;we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19.&nbsp;My guest is Tiana DiMichele, Director, Business Development, Impres Inc. Contact Information: Tiana DiMichele, Director, Business Development Phone: <a href="tel:%28416%29%20%20885-0023" rel="noopener noreferrer">(416) 885-0023</a> | E-mail: <a href="mailto:tianadimichele@imprespharma.ca" rel="noopener noreferrer">tianadimichele@imprespharma.ca</a>

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.

Share Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Sign up to save your podcasts

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

More shows like The Pharma Podcast

Pharma and BioTech Daily